Astrazeneca admits serious side effects of the vaccine!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Find out everything about the current developments and legal steps regarding Astrazeneca's vaccine Vaxzevria and the TTS cases.

Erfahren Sie alles über die aktuellen Entwicklungen und rechtlichen Schritte zu Astrazenecas Impfstoff Vaxzevria und den TTS-Fällen.
Find out everything about the current developments and legal steps regarding Astrazeneca's vaccine Vaxzevria and the TTS cases.

Astrazeneca admits serious side effects of the vaccine!

In recent weeks, rumors about Astrazeneca's Covid-19 vaccine Vaxzevria have caused a stir. Many users on social networks claim that the EU has banned the vaccine. These reports have already reached over three thousand shares on Facebook. But the truth is clear: the EU has not banned the vaccine. Loud Bachhausen The approval was withdrawn at the request of Astrazeneca itself after production was stopped. The decline in vaccine availability has its roots in decreased interest and discussion about possible side effects.

Of the dangerous vaccination side effects, thrombosis with thrombocytopenia syndrome (TTS) has come into particular focus. AstraZeneca has stated in a London court that its vaccine can actually cause TTS in rare cases. How t online reported, this admission could now lead to claims for damages. This affects, among other things, 51 cases in London, which amount to possible compensation of 100 million pounds.

Review of the side effects

The TTS syndrome occurs only very rarely and is characterized by a combination of thrombocytopenia and thrombosis. According to that Flexicon TTS is an unusual clinical picture that was already described in 2021 in connection with the COVID-19 vaccines. Symptoms can occur a few days to a few weeks after vaccination and are manifested by sudden blood clots in unusual veins, often accompanied by a reduced number of blood platelets.

Another point that fueled the discussion are the recommendations of the Standing Vaccination Commission (Stiko), which changed the handling of Astrazeneca's vaccine in April 2021. At that time, there was a change in recommendations that recommended the vaccine only for people over 60 years of age because the risk of serious thromboembolic events was predominantly found in younger women. The extent of the risks remains a hot topic among the public.

Current developments and lawsuits

A class action lawsuit against Astrazeneca is currently underway in Great Britain. However, this renewed legal dispute is not aimed at the safety of the vaccine, but rather at increasing compensation for vaccine injuries. Law firm Leigh Day has criticized AstraZeneca for refusing to admit the link between the vaccine and TTS syndrome for a long time. AstraZeneca, however, rejects these allegations and emphasizes that all product information is well documented and available to the public.

Aside from the ongoing legal skirmishes, AstraZeneca must also provide information about all side effects of the vaccine for the period from December 27, 2020 to February 19, 2024 in order to better address further lawsuits and claims. Overall, the situation surrounding the Vaxzevria vaccine remains a complex issue that continues to require close attention.